The hormone replacement therapy market is witnessing substantial growth due to the rising occurrence of hormonal and targeted conditions such as menopause and osteoporosis, coupled with the growing ...
The global gynecology drugs market was valued at approximately USD 66.44 billion in 2023 and is projected to experience a healthy compound annual growth rate (CAGR) of 4.8% from 2024 to 2032, reaching ...